(Q32077002)

6 July 2017

1 reference

title

Nicotinic receptor abnormalities in Alzheimer's disease (English)

1 reference

6 July 2017

0 references

Court J

1

1 reference

6 July 2017

Martin-Ruiz C

2

1 reference

6 July 2017

Piggott M

3

1 reference

6 July 2017

Spurden D

4

1 reference

6 July 2017

Griffiths M

5

1 reference

6 July 2017

Perry E

6

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

6 July 2017

published in

Biological Psychiatry

1 reference

6 July 2017

volume

49

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

175-184

1 reference

Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Comparison of the regional expression of nicotinic acetylcholine receptor ?7 mRNA and [125I]-?-bungarotoxin binding in human postmortem brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nerve growth factor receptor-containing cholinergic neurons of the basal forebrain project to the thalamic reticular nucleus in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotinic Receptors and Cholinergic Neurotransmission in the Central Nervous System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

The fall and rise of neuronal alpha-bungarotoxin binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Differential Regulation of Neuronal Nicotinic Receptor Binding Sites Following Chronic Nicotine Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Cerebrovascular Degeneration Is Related to Amyloid‐β Protein Deposition in Alzheimer's Diseasea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Smoking and Alzheimer's disease: a review of the epidemiological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Neuronal Nicotinic Receptor Subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Clinical neurochemistry: developments in dementia research based on brain bank material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Autoradiographic distribution of [3H]nicotine binding in human cortex: relative abundance in subicular complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotine receptors are located on lateral geniculate nucleus terminals in cat visual cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Distribution of nicotinic receptors in the human hippocampus and thalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Location of nicotinic and muscarinic cholinergic and mu-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in the hippocampus and neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Presynaptic nicotinic ACh receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Identification of four classes of brain nicotinic receptors using beta2 mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Nucleus basalis lesions decrease alpha- and kappa-bungarotoxins binding in rat cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901116-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)01116-1

1 reference

6 July 2017

1 reference